webinar register page

Webinar banner
This webinar is for users with a Zoom account. New to Zoom? Sign up free.
PCSS Waiver Elibility Training - PART 1
This is PART 1 of the 8-hour waiver eligibility training.
NOTE: This training has a starting time of 5:00 pm Pacific Time Zone. Please check your time zone for start time. Please download the Zoom app prior to training. https://zoom.us/ent?zcid=2582

Physicians are required to apply to the Drug Enforcement Agency for a waiver to prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder. Those physicians who want to treat more than 30 patients at any one time, must take the 8-hour waiver course.

To treat more than 30 patients, Advanced Practice Registered Nurses (APRN) (NP/CNM/CNS/CRNA) and Physician Assistants (PAs) must complete 24 hours of specialized training to prescribe buprenorphine. The training includes 8 hours of waiver training and an additional 16 hours of training.

Students can take the course during their educational program and apply for their waiver when they obtain their full DEA license. The course certificate of completion does not expire.

The 1st half of the training is a 4.25-hour live webcast. The 2nd half of the course is a 3.75-hour on-your-own online study. An exam on Part 2 must be completed within 30 days of the webinar session.

Instructions on how to log on to Part 2 of the course will be provided ONLY to those who complete the Part 1 in its entirety. It is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions & case studies for the AOAAM to verify attendance. PHONE ONLY PARTICIPATION DOES NOT QUALIFY FOR PARTICIPATION CREDIT.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government

Sep 26, 2022 05:00 PM in Pacific Time (US and Canada)

Webinar logo
* Required information


William Morrone, DO
Dr. William Morrone is Medical Director at Recovery Pathways, investigator in a naloxone distribution for Mid-Michigan, Medical Director of 35th Circuit Shiawassee County Drug Court, Associate Professor of Family and Community Medicine, Michigan State University for 18 years and was Program Director of Family Medicine at Synergy Medical Education Alliance and liaison in the Dept of Psychiatry. He is triple board certified by the American Board of Addiction Medicine, American College of Osteopathic Family Practitioners and the American Academy of Pain Management. Dr. Morrone was a Ruth Fox faculty for the 42nd ASAM 2011 Medical-Scientific Conference Washington DC and is an active addiction educator and social advocate in pain management. Dr. Morrone is Director of the Saginaw Chippewa Tribal Court & commissioner on the Governor’s Impaired Driving Commission 2017-2019; he is also Assistant Prof Johns Hopkins School of Nursing.